Net Loss per Share (Tables)
|3 Months Ended|
Mar. 31, 2017
|Earnings Per Share [Abstract]|
|Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]||
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics and Subsidiaries for the three months ended March 31, 2017 and 2016 (in thousands except share and per share amounts):
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
Reference 1: http://www.xbrl.org/2003/role/presentationRef